Jack Birch Unit for Molecular Carcinogenesis, Department of Biology, University of York, York, United Kingdom.
PLoS One. 2010 Oct 26;5(10):e13621. doi: 10.1371/journal.pone.0013621.
Despite the well-documented association between loss of E-cadherin and carcinogenesis, as well as the link between restoration of its expression and suppression of proliferation in carcinoma cells, the ability of E-cadherin to modulate growth-promoting cell signalling in normal epithelial cells is less well understood and frequently contradictory. The potential for E-cadherin to co-ordinate different proliferation-associated signalling pathways has yet to be fully explored.
METHODOLOGY/PRINCIPAL FINDINGS: Using a normal human urothelial (NHU) cell culture system and following a calcium-switch approach, we demonstrate that the stability of NHU cell-cell contacts differentially regulates the Epidermal Growth Factor Receptor (EGFR)/Extracellular Signal-Regulated Kinase (ERK) and Phosphatidylinositol 3-Kinase (PI3-K)/AKT pathways. We show that stable cell contacts down-modulate the EGFR/ERK pathway, whilst inducing PI3-K/AKT activity, which transiently enhances cell growth at low density. Functional inactivation of E-cadherin interferes with the capacity of NHU cells to form stable calcium-mediated contacts, attenuates E-cadherin-mediated PI3-K/AKT induction and enhances NHU cell proliferation by allowing de-repression of the EGFR/ERK pathway and constitutive activation of β-catenin-TCF signalling.
CONCLUSIONS/SIGNIFICANCE: Our findings provide evidence that E-cadherin can differentially and concurrently regulate specific growth-related signalling pathways in a context-specific fashion, with direct, functional consequences for cell proliferation and population growth. Our observations not only reveal a novel, complex role for E-cadherin in normal epithelial cell homeostasis and tissue regeneration, but also provide the basis for a more complete understanding of the consequences of E-cadherin loss on malignant transformation.
尽管 E-钙黏蛋白的丧失与癌变之间存在着充分记录的关联,以及其表达的恢复与癌细胞增殖的抑制之间存在关联,但 E-钙黏蛋白调节正常上皮细胞中促进生长的细胞信号传导的能力还不太了解,并且经常存在矛盾。E-钙黏蛋白协调不同增殖相关信号通路的潜力尚未得到充分探索。
方法/主要发现:我们使用正常的人尿路上皮(NHU)细胞培养系统,并采用钙转换方法,证明 NHU 细胞-细胞接触的稳定性差异调节表皮生长因子受体(EGFR)/细胞外信号调节激酶(ERK)和磷脂酰肌醇 3-激酶(PI3-K)/蛋白激酶 B(AKT)途径。我们表明,稳定的细胞接触下调 EGFR/ERK 途径,同时诱导 PI3-K/AKT 活性,这在低细胞密度下短暂增强细胞生长。E-钙黏蛋白的功能失活会干扰 NHU 细胞形成稳定的钙介导接触的能力,减弱 E-钙黏蛋白介导的 PI3-K/AKT 诱导,并通过允许 EGFR/ERK 途径去抑制和β-连环蛋白-TCF 信号的组成性激活来增强 NHU 细胞增殖。
结论/意义:我们的研究结果提供了证据表明,E-钙黏蛋白可以以特定于上下文的方式差异并同时调节特定的与生长相关的信号通路,对细胞增殖和群体生长具有直接的功能后果。我们的观察结果不仅揭示了 E-钙黏蛋白在正常上皮细胞稳态和组织再生中的新的、复杂的作用,而且为更全面地理解 E-钙黏蛋白丧失对恶性转化的后果奠定了基础。